Literature DB >> 17305636

The assessment of oral health-related quality of life by factor analysis in patients with Behcet's disease and recurrent aphthous stomatitis.

G Mumcu1, O Hayran, D O Ozalp, N Inanc, S Yavuz, T Ergun, H Direskeneli.   

Abstract

BACKGROUND: The aim of the study was to test multidimensional properties of oral health impact profile-14 (OHIP-14) in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS) patients with active oral ulcers.
METHODS: Ninety-six BD patients, 28 patients with RAS and 117 healthy controls (HC) were included in this study. In patients with active oral ulcers, the frequency and healing time of ulcers were recorded. Multidimensional properties of OHIP-14 were examined by factor analysis.
RESULTS: Factor analysis revealed three subscales and explained 66.49% of overall variance in these patients with active oral ulcers. The score of Subscale 1 was positively correlated with the recurrence of oral ulcers per month (P = 0.037). Subscale 3 scores of the patients treated with colchicine were worse than those treated with immunosuppressives (P = 0.035).
CONCLUSIONS: The factor structure of OHIP-14 was found to be reliable and sensitive to clinical parameters and treatment modalities in active patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17305636     DOI: 10.1111/j.1600-0714.2007.00514.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  23 in total

1.  Exploratory factor analysis of the Oral Health Impact Profile.

Authors:  M T John; D R Reissmann; L Feuerstahler; N Waller; K Baba; P Larsson; A Celebić; G Szabo; K Rener-Sitar
Journal:  J Oral Rehabil       Date:  2014-06-09       Impact factor: 3.837

2.  Impacts of recurrent aphthous stomatitis on quality of life of 12- and 15-year-old Thai children.

Authors:  Sudaduang Krisdapong; Aubrey Sheiham; Georgios Tsakos
Journal:  Qual Life Res       Date:  2011-05-15       Impact factor: 4.147

3.  Factor analyses of the Oral Health Impact Profile - overview and studied population.

Authors:  Mike T John; Daniel R Reißmann; Leah Feuerstahler; Niels Waller; Kazuyoshi Baba; Pernilla Larsson; Asja Čelebić; Gyula Szabo; Ksenija Rener-Sitar
Journal:  J Prosthodont Res       Date:  2014-01-17       Impact factor: 4.642

Review 4.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

5.  Patient reported outcome and experience measures of oral disease in oral medicine.

Authors:  R Ní Ríordáin; P Wiriyakijja
Journal:  Br Dent J       Date:  2017-11-03       Impact factor: 1.626

Review 6.  [The significance of health-related quality of life in systemic vasculitides].

Authors:  K Herlyn; F Moosig; W L Gross
Journal:  Z Rheumatol       Date:  2010-05       Impact factor: 1.372

7.  Patterns of impaired oral health-related quality of life dimensions.

Authors:  M T John; K Rener-Sitar; K Baba; A Čelebić; P Larsson; G Szabo; W E Norton; D R Reissmann
Journal:  J Oral Rehabil       Date:  2016-03-30       Impact factor: 3.837

8.  Unmet need in Behcet's disease: most patients in routine follow-up continue to have oral ulcers.

Authors:  Fatma Alibaz-Oner; Gonca Mumcu; Zeynep Kubilay; Gulsen Ozen; Gulce Celik; Aslı Karadeniz; Meryem Can; Sibel Yilmaz Oner; Nevsun Inanc; Pamir Atagunduz; Tulin Ergun; Haner Direskeneli
Journal:  Clin Rheumatol       Date:  2014-04-16       Impact factor: 2.980

9.  Assessment of quality of life in patients with chronic oral mucosal diseases: a questionnaire-based study.

Authors:  Bijina Rajan; Junaid Ahmed; Nandita Shenoy; Ceena Denny; Ravikiran Ongole; Almas Binnal
Journal:  Perm J       Date:  2014

10.  Psychological stress and recurrent aphthous stomatitis.

Authors:  Camila de Barros Gallo; Maria Angela Martins Mimura; Norberto Nobuo Sugaya
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.